Compare GLPI & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLPI | HOLX |
|---|---|---|
| Founded | 2013 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Electronics |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 16.6B |
| IPO Year | 2013 | 1995 |
| Metric | GLPI | HOLX |
|---|---|---|
| Price | $48.85 | $75.69 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 13 |
| Target Price | $51.79 | ★ $77.89 |
| AVG Volume (30 Days) | 2.1M | ★ 2.2M |
| Earning Date | 05-25-2026 | 04-27-2026 |
| Dividend Yield | ★ 6.32% | N/A |
| EPS Growth | ★ 2.79 | N/A |
| EPS | ★ 2.95 | 0.79 |
| Revenue | $1,594,752,000.00 | ★ $4,100,500,000.00 |
| Revenue This Year | $8.04 | $4.74 |
| Revenue Next Year | $4.88 | $5.03 |
| P/E Ratio | ★ $16.74 | $95.82 |
| Revenue Growth | ★ 4.13 | 1.74 |
| 52 Week Low | $41.17 | $51.90 |
| 52 Week High | $52.25 | $75.74 |
| Indicator | GLPI | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 62.08 | 66.77 |
| Support Level | $45.54 | $74.53 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.91 | 0.23 |
| MACD | 0.11 | 0.04 |
| Stochastic Oscillator | 70.39 | 92.38 |
Gaming and Leisure Properties Inc, or GLP, is a self-administered and self-managed Pennsylvania real estate investment trust (REIT). It is engaged in acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. The company also extends loans that produce fixed or variable returns, which may convert into leased rent upon project completion or stabilization. Its portfolio consists of gaming and related facilities and amenities such as Ameristar Black Hawk, Bally's Casino, Argosy Casino Alton, Bally's Chicago, Hollywood Casino Aurora, and others located across different states in the United States.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.